The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding

FHAF de Man; F de Beer; A van der Laarse; H Jansen; JA Gevers Leuven; JHM Souverijn; TFFP Vroom; SCM Schoormans; J-C Fruchart; LM Havekes; AHM Smelt

doi:10.1016/S0021-9150(00)00409-3

The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding

FHAF de Man, F de Beer, A van der Laarse, H Jansen, JA Gevers Leuven, JHM Souverijn, TFFP Vroom, SCM Schoormans, J-C Fruchart, LM Havekes, AHM Smelt

Biochemistry

Research output: Contribution to journal › Article › Academic › peer-review

21 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	363-371
Number of pages	9
Journal	Atherosclerosis
Volume	153
DOIs	https://doi.org/10.1016/S0021-9150(00)00409-3
Publication status	Published - 2000

Research programs

EMC 05-03-21-01-00
EMC 05-03-38-04-00

Access to Document

10.1016/S0021-9150(00)00409-3

http://hdl.handle.net/1765/70402

Cite this

de Man, FHAF., de Beer, F., van der Laarse, A., Jansen, H., Gevers Leuven, JA., Souverijn, JHM., Vroom, TFFP., Schoormans, SCM., Fruchart, J.-C., Havekes, LM., & Smelt, AHM. (2000). The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding. Atherosclerosis, 153, 363-371. https://doi.org/10.1016/S0021-9150(00)00409-3

@article{31c8a8e4063b4cf9a2479ebd0b9f95f2,

title = "The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding",

author = "{de Man}, FHAF and {de Beer}, F and {van der Laarse}, A and H Jansen and {Gevers Leuven}, JA and JHM Souverijn and TFFP Vroom and SCM Schoormans and J-C Fruchart and LM Havekes and AHM Smelt",

year = "2000",

doi = "10.1016/S0021-9150(00)00409-3",

language = "Undefined/Unknown",

volume = "153",

pages = "363--371",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

}

de Man, FHAF, de Beer, F, van der Laarse, A, Jansen, H, Gevers Leuven, JA, Souverijn, JHM, Vroom, TFFP, Schoormans, SCM, Fruchart, J-C, Havekes, LM & Smelt, AHM 2000, 'The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding', Atherosclerosis, vol. 153, pp. 363-371. https://doi.org/10.1016/S0021-9150(00)00409-3

The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding. / de Man, FHAF; de Beer, F; van der Laarse, A et al.
In: Atherosclerosis, Vol. 153, 2000, p. 363-371.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding

AU - de Man, FHAF

AU - de Beer, F

AU - van der Laarse, A

AU - Jansen, H

AU - Gevers Leuven, JA

AU - Souverijn, JHM

AU - Vroom, TFFP

AU - Schoormans, SCM

AU - Fruchart, J-C

AU - Havekes, LM

AU - Smelt, AHM

PY - 2000

Y1 - 2000

U2 - 10.1016/S0021-9150(00)00409-3

DO - 10.1016/S0021-9150(00)00409-3

M3 - Article

SN - 0021-9150

VL - 153

SP - 363

EP - 371

JO - Atherosclerosis

JF - Atherosclerosis

ER -